Название продукции:2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine
IUPAC Name:2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine
- CAS:90213-66-4
- Молекулярная формула:C6H3Cl2N3
- Чистота:98%
- Номер в каталоге:CM103618
- Молекулярная масса:188.01
Только для использования в НИОКР..
Информация о продукции
- Номер CAS:90213-66-4
- Молекулярная формула:C6H3Cl2N3
- Точка плавления:-
- Smiles-код:ClC1=NC(Cl)=C2C=CNC2=N1
- Плотность:
- Номер в каталоге:CM103618
- Молекулярная масса:188.01
- Точка кипения:
- Номер Mdl:MFCD08059278
- Хранение:-20°C
Category Infos
- Pyrrolopyrimidines
- Fusion heterocyclic compounds have various biological activities, such as anticancer, antibacterial, antifungal and anti-inflammatory, and thus have been widely used in the field of medicinal chemistry. Pyrrolopyrimidines are a major class of fused heterocyclic compounds. Compared with single pyrrole and pyrimidine cores, pyrrolopyrimidines have more diverse and effective pharmacological characteristics as fusion scaffolds.
Column Infos
- Capivasertib
- On November 16, FDA approved Capivasertib for the treatment of hormone receptor (HR)-positive, human epidermal growth factor 2 (HER2)-negative locally advanced or metastatic breast cancer. Capivasertib is a highly selective inhibitor targeting three AKT subtypes (AKT1/2/3), which can block signals used by cancer cells for division and growth.